Waldron Private Wealth LLC Sells 1,198 Shares of STERIS plc (NYSE:STE)

Waldron Private Wealth LLC cut its stake in shares of STERIS plc (NYSE:STE - Free Report) by 51.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,148 shares of the medical equipment provider's stock after selling 1,198 shares during the quarter. Waldron Private Wealth LLC's holdings in STERIS were worth $236,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in STE. Bleakley Financial Group LLC raised its holdings in STERIS by 8.7% in the 3rd quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider's stock valued at $407,000 after buying an additional 134 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after acquiring an additional 529,308 shares during the last quarter. Assetmark Inc. lifted its holdings in shares of STERIS by 24.6% during the third quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider's stock worth $3,252,000 after purchasing an additional 2,647 shares during the period. KBC Group NV grew its stake in shares of STERIS by 52.0% in the third quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider's stock worth $2,928,000 after purchasing an additional 4,132 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in STERIS during the 3rd quarter worth $9,949,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on STE. Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Friday, November 8th. Stephens restated an "overweight" rating and set a $240.00 price target on shares of STERIS in a report on Thursday. StockNews.com lowered shares of STERIS from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, October 29th. Finally, JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

Insider Transactions at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of STERIS stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the transaction, the senior vice president now owns 11,372 shares of the company's stock, valued at $2,471,363.04. This trade represents a 12.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is currently owned by insiders.

STERIS Trading Up 2.1 %

Shares of STE stock traded up $4.61 during trading hours on Thursday, hitting $225.44. 1,332,373 shares of the company were exchanged, compared to its average volume of 512,328. The company has a 50 day simple moving average of $212.33 and a two-hundred day simple moving average of $224.59. The firm has a market cap of $22.25 billion, a P/E ratio of 51.47 and a beta of 0.84. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.55 and a current ratio of 2.41. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.78% and a net margin of 8.02%. Equities analysts anticipate that STERIS plc will post 9.11 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS's dividend payout ratio is currently 52.05%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.